RecallLookupBack to the product checker
Serious riskSerious risk

EU Safety Gate · Report-2022-11

Fairness · Cream

The product contains hydroquinone (declared value 2% by weight) which can cause skin irritation and dermatitis. It also contains mometasone (declared value 0,10% by weight). Mometasone is a corticosteroid that should be made available only under medical prescription: exposure to it could cause skinirritation and may lead to endocrine problems. The product does not comply with the Cosmetic Products Regulation.

Published
18 March 2022
Notifying authority
Sweden
Catalog checked
30 July 2026
What should you do?

Check the authority measure and original alert.

Type of economic operator taking notified measure(s): Retailer. Category of measure(s): Stop of sales. Date of entry into force: Unknown

Official source alert
Safety Gate reference
A12/00432/22
Batch
FR2002
Category
Cosmetics
Risk type
Chemical
Country of origin
Not published

Skin-lightening cream